Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances
Authors:
- 1 April 2021
- journal article
- Published by Wiley in Comprehensive Physiology
- Vol. 11 (2) , 1805-1829
Abstract
Inflammatory processes are increasingly recognized in the pathogenesis of the vascular remodeling that characterizes pulmonary arterial hypertension (PAH). Chronic inflammation may contribute to disease progression or serve as a biomarker of PAH severity. Furthermore, inflammatory pathways may represent possible therapeutic targets for novel PAH‐specific drugs beyond the currently approved therapies targeting the endothelin, nitric oxide/cyclic GMP, and prostacyclin biological pathways. The main focus of this article is to provide recent advances in the understanding of the role of inflammatory pathways in the pathogenesis of PAH from preclinical studies and current clinical data supporting chronic inflammation in PAH patients and to discuss emerging therapeutic implications. © 2021 American Physiological Society. Compr Physiol 11:1805‐1829, 2021.Keywords
This publication has 117 references indexed in Scilit:
- Inflammation induces endothelial‐to‐mesenchymal transition and promotes vascular calcification through downregulation of BMPR2The Journal of Pathology, 2018
- Circulating plasmablasts are elevated and produce pathogenic anti‐endothelial cell autoantibodies in idiopathic pulmonary arterial hypertensionEuropean Journal of Immunology, 2018
- Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseFree Radical Biology and Medicine, 2015
- The varying faces of IL-6: From cardiac protection to cardiac failureCytokine, 2015
- BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary HypertensionCell Metabolism, 2015
- Updated assessment of the prevalence, spectrum and case definition of autoimmune diseaseAutoimmunity Reviews, 2012
- Plexiform Lesions in Pulmonary Arterial HypertensionThe American Journal of Pathology, 2011
- Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosisBiochemical Pharmacology, 2008
- Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three casesArthritis & Rheumatism, 2008
- Mycophenolate mofetil attenuates pulmonary arterial hypertension in ratsBiochemical and Biophysical Research Communications, 2006